Updated on 22 June 2012
It acquired a controlling stake in Suzhou Hyssen Electronics,which is China's market leader in automated urine sediment analyzers. With this acquisition, Mindray made its foray into urine sediment analysis for kidney and urinary tract diseases, the market for which is growing at 30 percent. It also got approval from the US FDA as well for its A5 Anaesthesia System, an anaesthesia delivery platform.
Further strengthening its profile, Mindray acquired a controlling stake of Hunan Changsha Tiandiren, a manufacturer of microbiology analysis solutions. With this strategic investment, Mindray achieved specialization in microbial identification and antibiotic susceptibility testing (ID/AST) and the blood culture system.